Parexel will offer the PS Biomarker Services to biopharma firms seeking biomarkers to assess new compounds.
The company has completed paying off a $600,000 settlement agreement for using Health Discovery Corporation's SVM IP for protein biomarker discovery.
The papers by members of NCI's proteomics group and NIST provide new tools and solutions for the proteomics community in the quest to upgrade the quality of their research.
The pharmaceutical firm will have access to GeneNews' genomic biomarker program.
A new bill puts biomarkers and biorepositories for cancer research on the front burner.
Included is a paper on the use of a mass spectrometry-based strategy for the absolute quantification of protein complex components, one using SISCAPA technology, and one showing that top-down proteomics can be done using CID on a q-TOF instrument.
The Guardian reports that some UK physicians are calling for increased regulation of direct-to-consumer genetic tests.
US tax agency says 23andMe's genetic health test can be claimed as a medical expense for tax purposes, the Wall Street Journal reports.
Two Democratic lawmakers argue at USA Today that independent science is under attack by the Trump Administration.
In PLOS this week: networks of genes co-expressed in depression, role of minichromosome maintenance genes in lung adenocarcinoma, and more.